APA (7th ed.) Citation

Tezel, O., Hutson, T. K., Gist, K. M., Chima, R. S., Goldstein, S. L., & Stanski, N. L. (2023). Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series. Critical care explorations, 5(9), e0978. https://doi.org/10.1097/CCE.0000000000000978

Chicago Style (17th ed.) Citation

Tezel, Oguzhan, Tamara K. Hutson, Katja M. Gist, Ranjit S. Chima, Stuart L. Goldstein, and Natalja L. Stanski. "Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series." Critical Care Explorations 5, no. 9 (2023): e0978. https://doi.org/10.1097/CCE.0000000000000978.

MLA (9th ed.) Citation

Tezel, Oguzhan, et al. "Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series." Critical Care Explorations, vol. 5, no. 9, 2023, p. e0978, https://doi.org/10.1097/CCE.0000000000000978.